Commonwealth Equity Services’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $71K | Buy |
60,987
+300
| +0.5% | +$349 | ﹤0.01% | 4120 |
|
|
2025
Q1 | $96K | Sell |
60,687
-3,258
| -5% | -$5.15K | ﹤0.01% | 4000 |
|
|
2024
Q4 | $194K | Hold |
63,945
| – | – | ﹤0.01% | 3773 |
|
|
2024
Q3 | $235K | Buy |
63,945
+3,250
| +5% | +$11.9K | ﹤0.01% | 3562 |
|
|
2024
Q2 | $248K | Sell |
60,695
-200
| -0.3% | -$817 | ﹤0.01% | 3476 |
|
|
2024
Q1 | $960K | Buy |
60,895
+6,640
| +12% | +$105K | ﹤0.01% | 2270 |
|
|
2023
Q4 | $822K | Buy |
54,255
+37,275
| +220% | +$565K | ﹤0.01% | 2310 |
|
|
2023
Q3 | $341K | Buy |
16,980
+6,730
| +66% | +$135K | ﹤0.01% | 2912 |
|
|
2023
Q2 | $289K | Buy |
+10,250
| New | +$289K | ﹤0.01% | 3082 |
|